EKF Diagnostics (EKF) Competitors GBX 26.70 -0.30 (-1.11%) As of 12:07 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock EKF vs. NIOX, NCYT, CREO, IUG, and IHCShould you buy EKF Diagnostics stock or one of its competitors? MarketBeat compares EKF Diagnostics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with EKF Diagnostics include NIOX Group (NIOX), Novacyt (NCYT), Creo Medical Group (CREO), Intelligent Ultrasound Group (IUG), and Inspiration Healthcare Group (IHC). These companies are all part of the "medical devices" industry. EKF vs. NIOXEKF vs. NCYTEKF vs. CREOEKF vs. IUGEKF vs. IHCHow does EKF Diagnostics compare to NIOX Group?EKF Diagnostics (LON:EKF) and NIOX Group (LON:NIOX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, dividends, valuation, risk, profitability, earnings and analyst recommendations. Does the media refer more to EKF or NIOX? In the previous week, EKF Diagnostics had 2 more articles in the media than NIOX Group. MarketBeat recorded 3 mentions for EKF Diagnostics and 1 mentions for NIOX Group. EKF Diagnostics' average media sentiment score of 0.00 equaled NIOX Group'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment EKF Diagnostics 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NIOX Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is EKF or NIOX more profitable? NIOX Group has a net margin of 14.37% compared to EKF Diagnostics' net margin of 4.12%. NIOX Group's return on equity of 10.14% beat EKF Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets EKF Diagnostics4.12% 3.01% 5.27% NIOX Group 14.37%10.14%3.95% Do insiders & institutionals hold more shares of EKF or NIOX? 22.6% of EKF Diagnostics shares are owned by institutional investors. Comparatively, 17.4% of NIOX Group shares are owned by institutional investors. 39.7% of EKF Diagnostics shares are owned by company insiders. Comparatively, 4.9% of NIOX Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has higher valuation and earnings, EKF or NIOX? NIOX Group has lower revenue, but higher earnings than EKF Diagnostics. NIOX Group is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEKF Diagnostics£51.56M2.23£4.68M£0.4756.81NIOX Group£48.70M5.25£995.88M£1.6437.07 Which has more volatility & risk, EKF or NIOX? EKF Diagnostics has a beta of 0.491, meaning that its stock price is 51% less volatile than the broader market. Comparatively, NIOX Group has a beta of 0.92, meaning that its stock price is 8% less volatile than the broader market. Do analysts rate EKF or NIOX? EKF Diagnostics presently has a consensus price target of GBX 35, suggesting a potential upside of 31.09%. NIOX Group has a consensus price target of GBX 86, suggesting a potential upside of 41.45%. Given NIOX Group's higher probable upside, analysts plainly believe NIOX Group is more favorable than EKF Diagnostics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score EKF Diagnostics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00NIOX Group 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryNIOX Group beats EKF Diagnostics on 7 of the 13 factors compared between the two stocks.How does EKF Diagnostics compare to Novacyt?EKF Diagnostics (LON:EKF) and Novacyt (LON:NCYT) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, media sentiment, earnings, analyst recommendations, institutional ownership, profitability and risk. Do insiders and institutionals have more ownership in EKF or NCYT? 22.6% of EKF Diagnostics shares are owned by institutional investors. Comparatively, 10.7% of Novacyt shares are owned by institutional investors. 39.7% of EKF Diagnostics shares are owned by company insiders. Comparatively, 0.5% of Novacyt shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Do analysts rate EKF or NCYT? EKF Diagnostics currently has a consensus target price of GBX 35, suggesting a potential upside of 31.09%. Given EKF Diagnostics' stronger consensus rating and higher possible upside, analysts clearly believe EKF Diagnostics is more favorable than Novacyt.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score EKF Diagnostics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Novacyt 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has higher earnings and valuation, EKF or NCYT? EKF Diagnostics has higher revenue and earnings than Novacyt. Novacyt is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEKF Diagnostics£51.56M2.23£4.68M£0.4756.81Novacyt£20.03M2.21-£36.80M-£43.00N/A Which has more risk & volatility, EKF or NCYT? EKF Diagnostics has a beta of 0.491, meaning that its share price is 51% less volatile than the broader market. Comparatively, Novacyt has a beta of 0.973, meaning that its share price is 3% less volatile than the broader market. Does the media favor EKF or NCYT? In the previous week, EKF Diagnostics had 3 more articles in the media than Novacyt. MarketBeat recorded 3 mentions for EKF Diagnostics and 0 mentions for Novacyt. EKF Diagnostics' average media sentiment score of 0.00 equaled Novacyt'saverage media sentiment score. Company Overall Sentiment EKF Diagnostics Neutral Novacyt Neutral Is EKF or NCYT more profitable? EKF Diagnostics has a net margin of 4.12% compared to Novacyt's net margin of -135.96%. EKF Diagnostics' return on equity of 3.01% beat Novacyt's return on equity.Company Net Margins Return on Equity Return on Assets EKF Diagnostics4.12% 3.01% 5.27% Novacyt -135.96%-111.34%-27.98% SummaryEKF Diagnostics beats Novacyt on 14 of the 15 factors compared between the two stocks.How does EKF Diagnostics compare to Creo Medical Group?Creo Medical Group (LON:CREO) and EKF Diagnostics (LON:EKF) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, dividends, analyst recommendations, profitability and media sentiment. Does the media prefer CREO or EKF? In the previous week, EKF Diagnostics had 3 more articles in the media than Creo Medical Group. MarketBeat recorded 3 mentions for EKF Diagnostics and 0 mentions for Creo Medical Group. Creo Medical Group's average media sentiment score of 0.00 equaled EKF Diagnostics'average media sentiment score. Company Overall Sentiment Creo Medical Group Neutral EKF Diagnostics Neutral Which has higher valuation & earnings, CREO or EKF? EKF Diagnostics has higher revenue and earnings than Creo Medical Group. Creo Medical Group is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCreo Medical Group£4.60M10.31-£25.04M-£1.00N/AEKF Diagnostics£51.56M2.23£4.68M£0.4756.81 Is CREO or EKF more profitable? Creo Medical Group has a net margin of 768.18% compared to EKF Diagnostics' net margin of 4.12%. Creo Medical Group's return on equity of 32.72% beat EKF Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets Creo Medical Group768.18% 32.72% -20.09% EKF Diagnostics 4.12%3.01%5.27% Do institutionals and insiders hold more shares of CREO or EKF? 45.2% of Creo Medical Group shares are owned by institutional investors. Comparatively, 22.6% of EKF Diagnostics shares are owned by institutional investors. 4.1% of Creo Medical Group shares are owned by insiders. Comparatively, 39.7% of EKF Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has more risk and volatility, CREO or EKF? Creo Medical Group has a beta of 1.6238419, suggesting that its share price is 62% more volatile than the broader market. Comparatively, EKF Diagnostics has a beta of 0.491, suggesting that its share price is 51% less volatile than the broader market. Do analysts rate CREO or EKF? EKF Diagnostics has a consensus target price of GBX 35, suggesting a potential upside of 31.09%. Given EKF Diagnostics' stronger consensus rating and higher possible upside, analysts plainly believe EKF Diagnostics is more favorable than Creo Medical Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Creo Medical Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00EKF Diagnostics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryEKF Diagnostics beats Creo Medical Group on 10 of the 15 factors compared between the two stocks.How does EKF Diagnostics compare to Intelligent Ultrasound Group?EKF Diagnostics (LON:EKF) and Intelligent Ultrasound Group (LON:IUG) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, valuation, dividends, profitability and analyst recommendations. Which has more volatility and risk, EKF or IUG? EKF Diagnostics has a beta of 0.491, meaning that its stock price is 51% less volatile than the broader market. Comparatively, Intelligent Ultrasound Group has a beta of 0.38, meaning that its stock price is 62% less volatile than the broader market. Do analysts recommend EKF or IUG? EKF Diagnostics presently has a consensus price target of GBX 35, indicating a potential upside of 31.09%. Given EKF Diagnostics' stronger consensus rating and higher probable upside, equities analysts plainly believe EKF Diagnostics is more favorable than Intelligent Ultrasound Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score EKF Diagnostics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Intelligent Ultrasound Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is EKF or IUG more profitable? EKF Diagnostics has a net margin of 4.12% compared to Intelligent Ultrasound Group's net margin of -23.11%. EKF Diagnostics' return on equity of 3.01% beat Intelligent Ultrasound Group's return on equity.Company Net Margins Return on Equity Return on Assets EKF Diagnostics4.12% 3.01% 5.27% Intelligent Ultrasound Group -23.11%-23.58%-13.51% Do institutionals & insiders believe in EKF or IUG? 22.6% of EKF Diagnostics shares are owned by institutional investors. Comparatively, 75.5% of Intelligent Ultrasound Group shares are owned by institutional investors. 39.7% of EKF Diagnostics shares are owned by insiders. Comparatively, 12.8% of Intelligent Ultrasound Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has better valuation and earnings, EKF or IUG? EKF Diagnostics has higher revenue and earnings than Intelligent Ultrasound Group. Intelligent Ultrasound Group is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEKF Diagnostics£51.56M2.23£4.68M£0.4756.81Intelligent Ultrasound Group£6.57M0.00-£2.27M-£0.68N/A Does the media favor EKF or IUG? In the previous week, EKF Diagnostics had 3 more articles in the media than Intelligent Ultrasound Group. MarketBeat recorded 3 mentions for EKF Diagnostics and 0 mentions for Intelligent Ultrasound Group. EKF Diagnostics' average media sentiment score of 0.00 equaled Intelligent Ultrasound Group'saverage media sentiment score. Company Overall Sentiment EKF Diagnostics Neutral Intelligent Ultrasound Group Neutral SummaryEKF Diagnostics beats Intelligent Ultrasound Group on 13 of the 14 factors compared between the two stocks.How does EKF Diagnostics compare to Inspiration Healthcare Group?Inspiration Healthcare Group (LON:IHC) and EKF Diagnostics (LON:EKF) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, media sentiment, risk, profitability and institutional ownership. Which has higher valuation & earnings, IHC or EKF? EKF Diagnostics has higher revenue and earnings than Inspiration Healthcare Group. Inspiration Healthcare Group is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInspiration Healthcare Group£45.20M0.58-£12.20M-£13.65N/AEKF Diagnostics£51.56M2.23£4.68M£0.4756.81 Does the media prefer IHC or EKF? In the previous week, EKF Diagnostics had 3 more articles in the media than Inspiration Healthcare Group. MarketBeat recorded 3 mentions for EKF Diagnostics and 0 mentions for Inspiration Healthcare Group. Inspiration Healthcare Group's average media sentiment score of 0.00 equaled EKF Diagnostics'average media sentiment score. Company Overall Sentiment Inspiration Healthcare Group Neutral EKF Diagnostics Neutral Is IHC or EKF more profitable? EKF Diagnostics has a net margin of 4.12% compared to Inspiration Healthcare Group's net margin of -25.32%. EKF Diagnostics' return on equity of 3.01% beat Inspiration Healthcare Group's return on equity.Company Net Margins Return on Equity Return on Assets Inspiration Healthcare Group-25.32% -69.35% -3.47% EKF Diagnostics 4.12%3.01%5.27% Which has more risk and volatility, IHC or EKF? Inspiration Healthcare Group has a beta of 0.717, indicating that its stock price is 28% less volatile than the broader market. Comparatively, EKF Diagnostics has a beta of 0.491, indicating that its stock price is 51% less volatile than the broader market. Do analysts prefer IHC or EKF? EKF Diagnostics has a consensus price target of GBX 35, indicating a potential upside of 31.09%. Given EKF Diagnostics' stronger consensus rating and higher probable upside, analysts clearly believe EKF Diagnostics is more favorable than Inspiration Healthcare Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspiration Healthcare Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00EKF Diagnostics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders hold more shares of IHC or EKF? 8.2% of Inspiration Healthcare Group shares are owned by institutional investors. Comparatively, 22.6% of EKF Diagnostics shares are owned by institutional investors. 8.4% of Inspiration Healthcare Group shares are owned by company insiders. Comparatively, 39.7% of EKF Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryEKF Diagnostics beats Inspiration Healthcare Group on 14 of the 15 factors compared between the two stocks. Get EKF Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for EKF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EKF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EKF vs. The Competition ExportMetricEKF DiagnosticsMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£116.24M£2.08B£6.25B£2.90BDividend Yield4.65%2.67%2.80%6.17%P/E Ratio56.8113.8920.79365.16Price / Sales2.23129.88531.2187,648.92Price / Cash10.6415.9943.0927.89Price / Book1.734.489.817.62Net Income£4.68M£144.75M£3.55B£5.89B7 Day Performance2.69%-1.93%-2.07%0.11%1 Month Performance8.98%1.00%-3.90%0.27%1 Year Performance6.80%8.16%29.39%83.47% EKF Diagnostics Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EKFEKF Diagnostics1.8421 of 5 starsGBX 26.70-1.1%GBX 35+31.1%+4.7%£116.24M£51.56M56.81356News CoverageNIOXNIOX Group2.033 of 5 starsGBX 62.40flatGBX 86+37.8%-11.5%£262.34M£48.70M38.0592NCYTNovacytN/AGBX 77.40+65.7%N/A+18.9%£56.09M£20.03MN/A120Gap UpHigh Trading VolumeCREOCreo Medical GroupN/AGBX 12.20-2.8%N/A+17.5%£50.32M£4.60MN/A279Gap DownIUGIntelligent Ultrasound GroupN/AN/AN/AN/A£42.76M£6.57MN/A65 Related Companies and Tools Related Companies NIOX Competitors NCYT Competitors CREO Competitors IUG Competitors IHC Competitors RUA Competitors AVO Competitors MHC Competitors SUN Competitors BELL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:EKF) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EKF Diagnostics Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share EKF Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
